An Aggressive Microcystic Adnexal Carcinoma Infiltrating the Sternum
February 2017 | Volume 16 | Issue 2 | Case Report | 180 | Copyright © 2017
Laura F. Sandoval DOa and Howard Steinman MDb
aSampson Regional Medical Center, Clinton, NC bDermOne Dermatology Centers, Irving, TX
Microcystic adnexal carcinoma is a rare cutaneous tumor that is often misdiagnosed and has the potential to be aggressive. Mohs surgery is the treatment of choice to prevent recurrences. We present a case of a large recurrent microcystic adnexal carcinoma on the sternum, initially diagnosed as a basal cell carcinoma. This tumor infiltrated the muscle and bone and was unresectable with Mohs surgery.
J Drugs Dermatol. 2017;16(2):180-181.
Purchase Original Article
Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.
Download the original manuscript as it was published in the JDD.
Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.
To get access to JDD's full-text articles and archives, upgrade here.
Save an unformatted copy of this article for on-screen viewing.
Print the full-text of article as it appears on the JDD site.→ proceed | ↑ close
A 59-year-old male presented with a non-healing lesion on the sternum (Figure 1) where a basal cell carcinoma (BCC) had been excised 7 years prior. The surgical scar had enlarged over the past 6 months, with a recent history of bleeding. Examination showed a 6.5 x 4.5 cm, firm, brown, and pink plaque with central erosion fixed to underlying tissues. A shave biopsy was performed showing a poorly circumscribed neoplasm comprised of nests of basaloid cells with mitotic figures exhibiting peripheral palisading and clefting (Figure 2). A diagnosis of recurrent sclerosing BCC was made.The patient was referred for Mohs surgery (MS). The first stage of MS showed evident tumor extending to muscle and bone. Frozen section pathology showed extensive persistent tumor at the peripheral and deep margins composed of numerous cords and small nests of basaloid cells, some with ductal differentiation in a desmoplastic stroma (Figure 3a, 3b). A revised tumor diagnosis of microcystic adnexal carcinoma (MAC) was made. A second stage removed additional involved deep soft tissue and cleared the peripheral surgical margins with a final defect measuring 12 x 12 cm. Persistent deep tumor involved bone, muscle, and tracheal lining (Figure 4). The patient was referred to plastic surgery where anterior chest wall resection was required to clear the tumor.
MAC is a rare cutaneous tumor that occurs most commonly in middle aged adults on the head and neck, with a predilection for the central face. These tumors are often misdiagnosed, especially after superficial biopsies. A study of 44 cases found 32.5% were misdiagnosed on biopsy, most commonly as BCC (25%),1 and are also commonly misdiagnosed as desmoplastic trichoepitheliomas or trichoadenomas. Data from a 2010 National Cancer Institute database showed 74% of the 223 cases of MAC where located on the head and neck, with only 7% on the trunk. Local invasion of fat, muscle, or bone was present in 9% of the cases. Additionally, 1 case showed metastatic disease and 3 cases (1%) had lymph node involvement.2 The treatment of choice is MS, which has the lowest recurrence rates.3 Recurrence rates of MAC treated with MS vary from 5% up to 10.3%.1;4 Wide local excision is also effective, however positive margins and recurrence rates are higher.3This case is unusual in that it was a large, deeply invasive, recurrent MAC of the chest involving muscle and bone, and was unresectable with MS. Recurrent MAC, perineural involvement, and periocular lesions have been reported to be associated with residual tumor after MS.1;4 This case demonstrates the need to clear the peripheral soft tissue margins and carefully photo-document the location of residual cancer when a case unresectable with MS is referred for continued extirpative care.
Drs. Sandoval and Steinman have no conflicts to disclose.